🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Y si le regresamos a decir Insuficiencia renal aguda como los españoles?, a mi el termino Lesión renal siempre me ha parecido terrible. #changemymind

In patients with CKD who are non-diabetic, sodium-glucose cotransporter 2 inhibitors (SGLT2i) may slow eGFR decline. Read more: kidney.pub/KID0886 #ASNKidney360

Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial MIRO-CKD is a fully recruited global trial enrolling a contemporary CKD population at increased risk of progression and with an increased risk of

After decades of promising epidemiological & experimental studies, we finally realize that CKD-MBD might have been the wrong therapeutical target for dialysis patients. #HiLo (admittedly smaller than conceived, but straightforward negative). Daniel Edmonston markusathome

Underscores importance of ongoing PHOSPHATE trial evaluating liberal vs stringent PO4 control in ESKD Pop: >3,000 patients PEP: MACE Sunil Badve RathikaKrish AKTN & collaborators aktn.org.au/phosphate-tria…

Ten tips for an onco-nephrology clinic. 🟢 Algoritmo Diagnóstico y tratamiento de lesión renal aguda en pacientes que utilizan inhibidores de checkpoint https:/doi.org/10.1093/ckj/sfaf174

Algorithmic approach to Peritoneal Dialysis (PD) Catheter OUTFLOW FAILURE #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/20630641/

Se confirma lo que sabíamos LDL no se aproxima normalmente a las células endoteliales Glicocalix lo repele, por cargas iguales -¿Entonces...la retención de LDL en el subendotelio es mentira? Claro, las cosas no pasan de esa forma doi.org/10.1016/j.ajpa…

New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic. academic.oup.com/jcem/advance-a…

Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality.(JASN 2025) El retiro de RASi dentro de 2 días de LRA se asoció con disminución mortalidad a 30 días 4.3% vs 5.9% DOI: 10.1681/ASN.0000000775

🚀 #Finerenone now FDA‑approved for #HFpEF / #HFmrEF, yet key gaps remain.  MOONRAKER (REDEFINE, CONFIRMATION, FINALITY) is enrolling to test early use, combo therapy & options for MRA‑intolerant #HFrEF.  Join in—search finerenone at clinicaltrials.gov.

Gran tweetorial.

Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease academic.oup.com/eurheartj/arti…

Guía NAC de la ATS 2025,por que es una complicación frecuente en jnuestros pacientes nefropatas.

La lesión renal aguda durante el embarazo ↑13 veces el riesgo de morir en la hospitalización; a largo plazo, ↑9 veces el de eventos cardiovasculares El consenso ADQI 32 muestra las etiologías acorde al trimestre de presentación Nat Rev Nephrol 2025 10.1038/s41581-025-00979-6

Perspective by Andrew J. Cohen: Is Dialysis Nephrology’s Original Sin? bit.ly/41UQC6W

La furosemida tiene >18,000 publicaciones, demostrando múltiples beneficios, pero también algunos efectos adversos, el más nuevo, su asociación e interacción con las toxinas uremicas ligadas a proteínas. Kidney Int Rep 2025 doi.org/10.1016/j.ekir…